Terms: = Ovarian cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
33 results:
1. Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression.
Zhao L; Huang J; Liu W; Su X; Zhao B; Wang X; He X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):179. PubMed ID: 38584230
[TBL] [Abstract] [Full Text] [Related]
2. PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway.
Wu J; Wu Y; Chen S; Guo Q; Shao Y; Liu C; Lin K; Wang S; Zhu J; Chen X; Ju X; Xia L; Wu X
Oncogene; 2024 Mar; 43(12):866-883. PubMed ID: 38297082
[TBL] [Abstract] [Full Text] [Related]
3. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
[TBL] [Abstract] [Full Text] [Related]
4. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
Chen J; Hu Q; Zhou C; Jin D
Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
[TBL] [Abstract] [Full Text] [Related]
5. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
6. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
[TBL] [Abstract] [Full Text] [Related]
7. UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and Nrf2-mediated antioxidant activity in ovarian cancer.
Hong X; Ma N; Li D; Zhang M; Dong W; Huang J; Ci X; Zhang S
Cell Death Dis; 2023 Feb; 14(2):100. PubMed ID: 36765041
[TBL] [Abstract] [Full Text] [Related]
8. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
9. GBAS Regulates the Proliferation and Metastasis of ovarian cancer Cells by Combining with eEF1A1.
Ning X; Shi G; Ren S; Liu S; Ding J; Zhang R; Li L; Xie Q; Xu W; Meng F; Ma R
Oncologist; 2022 Feb; 27(1):e64-e75. PubMed ID: 35305106
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA DARS-AS1 regulates TP53 ubiquitination and affects ovarian cancer progression by modulation miR-194-5p/RBX1 axis.
Zhou M; Cheng H; Fu Y; Zhang J
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22865. PubMed ID: 34328246
[TBL] [Abstract] [Full Text] [Related]
11. CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression.
Li X; Yang KB; Chen W; Mai J; Wu XQ; Sun T; Wu RY; Jiao L; Li DD; Ji J; Zhang HL; Yu Y; Chen YH; Feng GK; Deng R; Li JD; Zhu XF
Autophagy; 2021 Dec; 17(12):4323-4340. PubMed ID: 33977871
[TBL] [Abstract] [Full Text] [Related]
12. Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.
Mallen A; Todd S; Robertson SE; Kim J; Sehovic M; Wenham RM; Extermann M; Chon HS
Gynecol Oncol; 2021 Jun; 161(3):693-699. PubMed ID: 33812698
[TBL] [Abstract] [Full Text] [Related]
13. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract] [Full Text] [Related]
14. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
15. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
16. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
Chovancova B; Liskova V; Miklikova S; Hudecova S; Babula P; Penesova A; Sevcikova A; Durinikova E; Novakova M; Matuskova M; Krizanova O
Biochem Pharmacol; 2020 Jan; 171():113695. PubMed ID: 31706846
[TBL] [Abstract] [Full Text] [Related]
17. Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look".
Grette K; Long B; Finan MA; Rocconi RP
Gynecol Oncol; 2019 Aug; 154(2):290-293. PubMed ID: 31160072
[TBL] [Abstract] [Full Text] [Related]
18. Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.
Murono K; Nagata H; Ishimaru K; Emoto S; Kaneko M; Hiyoshi M; Sasaki K; Otani K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H; Muro K; Ishihara S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):145-150. PubMed ID: 30386886
[TBL] [Abstract] [Full Text] [Related]
19. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract] [Full Text] [Related]
20. Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
Fanelli M; Camperchioli A; Petrella L; Petrillo M; Baranello C; Baccaro P; Paolillo C; Capoluongo E; Scambia G
Int J Biol Markers; 2018 Jan; 33(1):124-131. PubMed ID: 29218693
[TBL] [Abstract] [Full Text] [Related]
[Next]
